Explore how EGFR tyrosine kinase inhibitors reverse EMT and inhibit metastasis in inflammatory breast cancer through cellular reprogramming.
Exploring how non-coding CK19 RNA fragments serve as biomarkers for breast cancer detection and monitoring through liquid biopsies
Discover how COL11A1, a once-overlooked protein, is emerging as a powerful biomarker for breast cancer prognosis and treatment.